Breaking News

Theorem Executives to Speak at PCT

By Kristin Brooks | March 24, 2014

Will address clinical data analytics

Three executives from Theorem Clinical Research will present at the 23rd Annual Partnerships in Clinical Trials in Las Vegas, NV, March 31 - April 2.
 
President and chief executive officer, John Potthoff, will speak on “The Real Impact of Going Public/Private on Business,” 2:00 p.m. – 3:00 p.m. on Monday, March 31. Alison Taber, vice president of global data management, will join a panel discussion on the topic of “Risk-Based Study Management for Small to Midsized Companies,” 2:30 p.m. - 3:30 p.m. on March 31. Also, Mark Penniston, executive vice president and general manager of Clinical Analytics, will discuss visual analytics and real-world applications at 4:30 p.m. on Tuesday, April 1.
           
“The amount of data collected in modern clinical trials can be completely overwhelming unless you have ways to see it that make it meaningful,” Mr. Penniston said. “Theorem has been developing advanced visual analytics tools and techniques that allow us to present complex clinical information graphically, giving you a quicker grasp and greater insight into the meaning the numbers actually represent.”

Related Compliance:

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks

  • The Growing Realm of Real-World Data

    Kristin Brooks, Contract Pharma||November 8, 2016
    PPD's Evidera acquisition aims to help clients address the growing demand for evidence from regulators and payers

  • Mastering Immunotherapy Clinical Trials: Dosing and Response

    Mastering Immunotherapy Clinical Trials: Dosing and Response

    Kristin Brooks, Contract Pharma||August 1, 2016
    Andrew Zupnick of Novella Clinical provides insights into dosing and measuring response in immunotherapy clinical trials